A Multicentre Trial to Determine the Efficacy and Safety of AD-337 in the Treatment of Fibromyalgia
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This is a multicentre, randomized, double-blind, placebo controlled, parallel group
exploratory study to investigate the efficacy, safety and tolerability of AD 337 in the
treatment of fibromyalgia in female subjects.